Access to Meds (@pcmedsaccess) 's Twitter Profile
Access to Meds

@pcmedsaccess

Fighting pharma power since 2010 at @Public_Citizen. We work around the world to make sure people have access to lifesaving medicines.

RTs =/= Endorsements.

ID: 409476383

linkhttp://citizen.org/access calendar_today10-11-2011 19:55:52

4,4K Tweet

2,2K Followers

1,1K Following

Access to Meds (@pcmedsaccess) 's Twitter Profile Photo

.Peter Maybarduk on President Donald J. Trump negotiating Medicare drug prices for the first time, thanks to the Inflation Reduction Act: "This administration is stepping up its pressure on the pharmaceutical industry. It’s about giving folks a little breathing room." msn.com/en-us/health/o…

USA TODAY Opinion (@usatodayopinion) 's Twitter Profile Photo

"There is no rational reason why Americans, for decades, have been forced to pay, by far, the highest prices in the world for the prescription drugs they need," write President Donald J. Trump Joe Biden and Bernie Sanders. usatoday.com/story/opinion/…

Public Citizen (@public_citizen) 's Twitter Profile Photo

Pharmaceutical companies can make whatever excuses they want for their sky-high drug prices — we know it’s bullshit. And Biden and Bernie just called them on it. If Big Pharma won’t quell its own greed, it’s up to the government to do it for them. citizen.org/news/president…

David Mitchell (@davidp4ad) 's Twitter Profile Photo

Buyer Beware: There is a group called the Council For Affordable Health Coverage CAHC that claims to speak for the needs of patients & consumers. It's actually a pharma front group representing industry's interests. Follow this thread to see how PhRMA hides behind CAHC 1/5

Initiative for Medicines, Access & Knowledge (@imakglobal) 's Twitter Profile Photo

“We need to prevent these anticompetitive patents from being inappropriately granted at all.” Steve Knievel of Public Citizen explains what recent bills focused on patent thickets do and what more must be done to fully put a stop to drugmakers’ abuse of the patent system.

Public Citizen (@public_citizen) 's Twitter Profile Photo

Big Pharma companies are abusing the patent system to keep drug prices high at patients’ expense. This is corporate greed at work.

Bernie Sanders (@sensanders) 's Twitter Profile Photo

I’m pleased that Eli Lilly took a modest step forward by reducing the starter price of Zepbound. But let's be clear: Even with this modest price reduction, millions of Americans will still be unable to afford the diabetes and weight-loss drugs they desperately need.

I’m pleased that Eli Lilly took a modest step forward by reducing the starter price of Zepbound.

But let's be clear: Even with this modest price reduction, millions of Americans will still be unable to afford the diabetes and weight-loss drugs they desperately need.
Bernie Sanders (@sensanders) 's Twitter Profile Photo

Over the course of our investigation into the outrageous cost of Ozempic and Wegovy in the U.S., I spoke with the CEOs of major generic pharmaceutical companies who confirmed: They can sell a generic version of Ozempic for $100/mo. x.com/i/broadcasts/1…

More Perfect Union (@moreperfectus) 's Twitter Profile Photo

Today Bernie Sanders took the CEO of pharma giant Novo Nordisk to task over the cost of Wegovy. Wegovy, and identical drug Ozempic, could bankrupt Medicare. Big Pharma is charging Americans 10x what people around the world pay — and the effects could be catastrophic.

Peter Maybarduk (@maybarduk) 's Twitter Profile Photo

In 2016, Trump said pharma execs are "getting away w/ murder" and pledged to fight to lower drug prices. But as president, Trump's drug pricing plan appears to have been built around a “five-point plan” provided by PhRMA itself. We uncovered this through FOIA 1/

In 2016, Trump said pharma execs are "getting away w/ murder" and pledged to fight to lower drug prices.

But as president, Trump's drug pricing plan appears to have been built around a “five-point plan” provided by PhRMA itself.

We uncovered this through FOIA 1/
Peter Maybarduk (@maybarduk) 's Twitter Profile Photo

Pres. Trump met with pharma execs on Jan. 31, 2017, weeks after he took office. According to a PhRMA email to HHS, uncovered through FOIA, Trump gave the executives a “follow-up assignment” to present their drug pricing plan.

Emily Kopp (@emilyakopp) 's Twitter Profile Photo

One of my first big scoops was obtaining a yet-to-be-released executive order the first Trump administration was circulating. I wrote that it sounded like pharma lobbyists wrote it. A new FOIA shows that pharma lobbyists DID write it.

Peter Maybarduk (@maybarduk) 's Twitter Profile Photo

Bavarian Nordic charges UNICEF $65/dose for the mpox vax -- a price "far higher than nearly all vaccines used in public health programs." We spoke with AP: apnews.com/article/mpox-c…

Peter Maybarduk (@maybarduk) 's Twitter Profile Photo

WHO confirmed today that CDC has stopped sharing flu surveillance data through WHO platforms. The U.S. is facing its most intense flu season in 15 years and is grappling with bird flu. Trump’s recklessness is already risking the health of Americans and people worldwide. 1/2

Public Citizen (@public_citizen) 's Twitter Profile Photo

The Supreme Court sided with us and ruled that the Trump admin must obey court orders and pause its illegal freeze on foreign assistance funding. This is a huge win. Listen to our lawyer on the case, Lauren Bateman, break down what this means:

Public Citizen (@public_citizen) 's Twitter Profile Photo

Big Pharma is lobbying Congress to delay drug price negotiations by THIRTEEN YEARS. This would likely cost taxpayers tens of billions of dollars. Congress should be looking out for people, not Big Pharma's inflated profits.

Bernie Sanders (@sensanders) 's Twitter Profile Photo

Are you ready for a radical idea? The function of our health care system should be to provide quality care for all, not huge profits for the insurance companies and the drug companies.